Mario Masellis Selected Research

Neurotransmitter Agents (Neurotransmitter)

1/2023

Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Masellis Research Topics

Disease

32	Frontotemporal Dementia (Semantic Dementia) 04/2024 - 01/2011
31	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 12/2009
24	Dementia (Dementias) 03/2024 - 06/2013
18	Cognitive Dysfunction 03/2024 - 08/2016
17	Parkinson Disease (Parkinson's Disease) 12/2023 - 06/2013
15	Atrophy 01/2023 - 01/2018
11	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 01/2016
10	Disease Progression 04/2024 - 01/2006
8	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 11/2006
6	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 08/2016
5	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 12/2009
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2023 - 02/2016
4	Neuroinflammatory Diseases 09/2022 - 01/2017
4	Synucleinopathies 01/2020 - 12/2016
4	Parkinsonian Disorders (Parkinsonism) 01/2017 - 12/2016
4	Schizophrenia (Dementia Praecox) 06/2011 - 10/2002
3	Tauopathies 04/2023 - 01/2020
3	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 01/2014
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 10/2017
3	Hypertension (High Blood Pressure) 01/2021 - 01/2006
3	Corticobasal Degeneration 01/2020 - 11/2006
3	Multiple System Atrophy 01/2020 - 12/2016
3	Tardive Dyskinesia 06/2011 - 07/2002
2	Prodromal Symptoms 01/2023 - 01/2020
2	Gliosis 01/2022 - 01/2020
2	Primary Progressive Aphasia 01/2022 - 11/2018
2	Proteostasis Deficiencies 01/2022 - 01/2014
2	TDP-43 Proteinopathies 01/2022 - 01/2010
2	Mental Disorders (Mental Disorder) 10/2021 - 11/2006
2	REM Sleep Behavior Disorder 01/2021 - 07/2017
2	Syncope (Fainting) 01/2021 - 08/2016
2	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2018 - 05/2017
2	Proteinuria 05/2009 - 01/2006
2	Weight Gain 11/2002 - 10/2002
1	Obesity 05/2024
1	Headache (Headaches) 11/2023
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2023
1	Stroke (Strokes) 01/2023
1	Cerebral Small Vessel Diseases 01/2023
1	Thrombocytopenia (Thrombopenia) 05/2022

Drug/Important Bio-Agent (IBA)

45	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
12	Apolipoproteins E (ApoE)IBA 04/2024 - 12/2012
11	ProgranulinsIBA 01/2023 - 11/2006
8	ApolipoproteinsIBA 03/2024 - 01/2018
7	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2017
5	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023 - 01/2017
5	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 10/2002
5	GranulinsIBA 01/2022 - 01/2016
5	hydroxide ionIBA 01/2021 - 12/2016
4	Amyloid beta-PeptidesIBA 12/2023 - 01/2018
3	Glial Fibrillary Acidic ProteinIBA 12/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2017
3	Linoleic Acid (Linoleate)IBA 01/2023 - 10/2019
3	solanezumabIBA 11/2022 - 07/2021
3	gantenerumabIBA 11/2022 - 07/2021
3	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 01/2014
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021 - 01/2016
3	Antipsychotic Agents (Antipsychotics)IBA 06/2011 - 07/2002
2	Antihypertensive Agents (Antihypertensives)IBA 05/2024 - 08/2016
2	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2023 - 01/2023
2	Protein Isoforms (Isoforms)IBA 04/2023 - 01/2019
2	Monoclonal AntibodiesIBA 01/2023 - 12/2021
2	Epoxide HydrolasesIBA 01/2023 - 10/2019
2	OxylipinsIBA 01/2023 - 10/2019
2	N 30IBA 01/2023 - 01/2014
2	neuronal pentraxinIBA 01/2022 - 01/2020
2	Retinaldehyde (Retinal)IBA 01/2022 - 03/2017
2	Protons (Proton)IBA 01/2020 - 01/2017
2	SynucleinsIBA 01/2020 - 12/2016
2	Levodopa (L Dopa)FDA LinkGeneric 01/2018 - 05/2017
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2016 - 12/2009
2	UbiquitinIBA 01/2014 - 01/2010
2	Memantine (Namenda)FDA Link 03/2013 - 01/2011
2	Dopamine D3 ReceptorsIBA 06/2011 - 07/2002
2	Clozapine (Clozaril)FDA LinkGeneric 11/2002 - 10/2002
1	LDL CholesterolIBA 05/2024
1	Blood Proteins (Serum Proteins)IBA 11/2023
1	Glyburide (Glibenclamide)FDA LinkGeneric 10/2023
1	Gliclazide (Diamicron)IBA 10/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2023
1	AcidsIBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2023
1	Epoxy Compounds (Epoxides)IBA 01/2023
1	LysophospholipidsIBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Phosphorylcholine (Phosphocholine)IBA 01/2023
1	PrionsIBA 01/2023
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2023
1	Sodium-Glucose Transport ProteinsIBA 01/2023
1	Complement System Proteins (Complement)IBA 09/2022
1	Anticardiolipin AntibodiesIBA 05/2022
1	Antiphospholipid AntibodiesIBA 05/2022

Therapy/Procedure

10	Therapeutics 10/2023 - 03/2002
3	Activities of Daily Living (ADL) 12/2023 - 01/2019